European Commission logo
español español
CORDIS - Resultados de investigaciones de la UE
CORDIS

High Performance Soft-tissue Navigation

Descripción del proyecto

Ingenieros biomédicos y médicos noveles desarrollan nuevas tecnologías para la navegación a través de tejidos blandos

La navegación a través de tejidos blandos durante las operaciones, en concreto la resección quirúrgica de tumores, se ve obstaculizada por las dificultades para lograr la precisión deseada en órganos deformables que se mueven en respuesta a la respiración, los latidos del corazón y la propia intervención. Muchos pacientes aquejados de un carcinoma hepatocelular, el tipo principal de tumor maligno hepático primario, no son aptos para la resección quirúrgica, y el pronóstico de otros se ve afectado por las dificultades inherentes a la navegación a través de tejidos blandos. El equipo del proyecto HiPerNav, que cuenta con el apoyo de las acciones Marie Skłodowska-Curie, centrará sus esfuerzos en formar a investigadores noveles en relación con materias como los tratamientos mínimamente atraumáticos, la ingeniería biomédica o las metodologías de investigación y emprendimiento. La investigación tenderá un puente entre los conceptos teóricos y la práctica clínica a través de la prueba de prototipos y el desarrollo de tecnologías y herramientas para la vida real.

Objetivo

Primary liver cancer, which consists predominantly of hepatocellular carcinoma (HCC), is the fifth most common cancer worldwide and the third most common cause of cancer mortality. A successful surgical resection of HCC requires complete removal of the tumour while sparing as much healthy tissue as possible. Due to technical and clinical difficulties relatively low percentage of patients are eligible for resection. There is an urgent need to increase the patient eligibility and improve the survival prognosis after liver interventions. HiPerNav will train early stage researchers (biomedical engineers and medical doctors) to become international leading in key areas of expertise through a novel coordinated plan of individual research projects addressing specific bottlenecks in soft tissue navigation for improved treatment of liver cancer. The multi-disciplinary dialogue and work between clinicians and biomedical engineers is crucial to address these bottlenecks. By providing researchers with knowledge and training within specific topics from minimally invasive treatment, biomedical engineering, research methodologies, innovation and entrepreneurship, the link between academic research and industry will be strengthened. This allows for easy transfer of promising results from the research projects to commercially exploitable solutions. The global image guided surgery devices market is promising; it was valued at USD 2.76 billion in 2013 and is projected to expand 6.4% from 2014 to 2022 to reach USD 4.80 billion in 2022. The market for soft-tissue navigation is still in its infancy, mainly due to challenges in achieved accuracy for targeting deformable and moving organs. By providing multi-disciplinary training, the researchers in this consortium of international leading research institutions, universities and industry will initiate true translational research from academic theoretical ideas to the clinical testing of prototype, developed solutions and tools.

Coordinador

OSLO UNIVERSITETSSYKEHUS HF
Aportación neta de la UEn
€ 755 448,55
Dirección
KIRKEVEIEN 166 TARNBYGGET
0450 Oslo
Noruega

Ver en el mapa

Región
Norge Oslo og Viken Oslo
Tipo de actividad
Higher or Secondary Education Establishments
Enlaces
Coste total
€ 755 448,55

Participantes (9)

Socios (4)